Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties

Gursaran P Talwar,1 Jagdish C Gupta,1 Abu S Mustafa,2 Hemanta K Kar,3 Kiran Katoch,4 Shreemanta K Parida,5 Prabhakara P Reddi,6 Niyaz Ahmed,7 Vikram Saini,8 Somesh Gupta9 1Talwar Research Foundation, New Delhi, India; 2Department of Microbiology, Kuwait University, Kuwait; 3Department of Dermatology...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Talwar GP, Gupta JC, Mustafa AS, Kar HK, Katoch K, Parida SK, Reddi PP, Ahmed N, Saini V, Gupta S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/0de73b09bc9241ba84cba14971550178
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0de73b09bc9241ba84cba14971550178
record_format dspace
spelling oai:doaj.org-article:0de73b09bc9241ba84cba149715501782021-12-02T00:16:31ZDevelopment of a potent invigorator of immune responses endowed with both preventive and therapeutic properties1177-5491https://doaj.org/article/0de73b09bc9241ba84cba149715501782017-05-01T00:00:00Zhttps://www.dovepress.com/development-of-a-potent-invigorator-of-immune-responses-endowed-with-b-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Gursaran P Talwar,1 Jagdish C Gupta,1 Abu S Mustafa,2 Hemanta K Kar,3 Kiran Katoch,4 Shreemanta K Parida,5 Prabhakara P Reddi,6 Niyaz Ahmed,7 Vikram Saini,8 Somesh Gupta9 1Talwar Research Foundation, New Delhi, India; 2Department of Microbiology, Kuwait University, Kuwait; 3Department of Dermatology, Paras Hospital, Gurgaon, 4National JALMA Institute of Leprosy and Other Mycobacterial Diseases, Agra, India; 5German Centre of Infection, Justus Liebig University, Giessen, Germany; 6Department of Comparative Biosciences, University of Illinois Urbana Champaign, IL, USA; 7Department of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, India; 8Department of Microbiology, University of Alabama, Birmingham, AL, USA; 9Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India Abstract: This article reviews briefly the making of an immunoprophylactic-cum-immunotherapeutic vaccine against leprosy. The vaccine is based on cultivable, heat-killed atypical mycobacteria, whose gene sequence is now known. It has been named Mycobacterium indicus pranii. It has received the approval of the Drug Controller General of India and the US Food and Drug Administration. Besides leprosy, M. indicus pranii has found utility in the treatment of category II (“difficult to treat”) tuberculosis. It also heals ugly anogenital warts. It has preventive and therapeutic action against SP2/O myelomas. It is proving to be a potent adjuvant for enhancing antibody titers of a recombinant vaccine against human chorionic gonadotropin, with the potential of preventing pregnancy without derangement of ovulation and menstrual regularity in sexually active women. Keywords: leprosy, tuberculosis, anogenital warts, myeloma, adjuvantTalwar GPGupta JCMustafa ASKar HKKatoch KParida SKReddi PPAhmed NSaini VGupta SDove Medical PressarticleLeprosyTuberculosisAno-genital wartsMyelomaAdjuvantMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol Volume 11, Pp 55-63 (2017)
institution DOAJ
collection DOAJ
language EN
topic Leprosy
Tuberculosis
Ano-genital warts
Myeloma
Adjuvant
Medicine (General)
R5-920
spellingShingle Leprosy
Tuberculosis
Ano-genital warts
Myeloma
Adjuvant
Medicine (General)
R5-920
Talwar GP
Gupta JC
Mustafa AS
Kar HK
Katoch K
Parida SK
Reddi PP
Ahmed N
Saini V
Gupta S
Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
description Gursaran P Talwar,1 Jagdish C Gupta,1 Abu S Mustafa,2 Hemanta K Kar,3 Kiran Katoch,4 Shreemanta K Parida,5 Prabhakara P Reddi,6 Niyaz Ahmed,7 Vikram Saini,8 Somesh Gupta9 1Talwar Research Foundation, New Delhi, India; 2Department of Microbiology, Kuwait University, Kuwait; 3Department of Dermatology, Paras Hospital, Gurgaon, 4National JALMA Institute of Leprosy and Other Mycobacterial Diseases, Agra, India; 5German Centre of Infection, Justus Liebig University, Giessen, Germany; 6Department of Comparative Biosciences, University of Illinois Urbana Champaign, IL, USA; 7Department of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, India; 8Department of Microbiology, University of Alabama, Birmingham, AL, USA; 9Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India Abstract: This article reviews briefly the making of an immunoprophylactic-cum-immunotherapeutic vaccine against leprosy. The vaccine is based on cultivable, heat-killed atypical mycobacteria, whose gene sequence is now known. It has been named Mycobacterium indicus pranii. It has received the approval of the Drug Controller General of India and the US Food and Drug Administration. Besides leprosy, M. indicus pranii has found utility in the treatment of category II (“difficult to treat”) tuberculosis. It also heals ugly anogenital warts. It has preventive and therapeutic action against SP2/O myelomas. It is proving to be a potent adjuvant for enhancing antibody titers of a recombinant vaccine against human chorionic gonadotropin, with the potential of preventing pregnancy without derangement of ovulation and menstrual regularity in sexually active women. Keywords: leprosy, tuberculosis, anogenital warts, myeloma, adjuvant
format article
author Talwar GP
Gupta JC
Mustafa AS
Kar HK
Katoch K
Parida SK
Reddi PP
Ahmed N
Saini V
Gupta S
author_facet Talwar GP
Gupta JC
Mustafa AS
Kar HK
Katoch K
Parida SK
Reddi PP
Ahmed N
Saini V
Gupta S
author_sort Talwar GP
title Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
title_short Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
title_full Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
title_fullStr Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
title_full_unstemmed Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
title_sort development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/0de73b09bc9241ba84cba14971550178
work_keys_str_mv AT talwargp developmentofapotentinvigoratorofimmuneresponsesendowedwithbothpreventiveandtherapeuticproperties
AT guptajc developmentofapotentinvigoratorofimmuneresponsesendowedwithbothpreventiveandtherapeuticproperties
AT mustafaas developmentofapotentinvigoratorofimmuneresponsesendowedwithbothpreventiveandtherapeuticproperties
AT karhk developmentofapotentinvigoratorofimmuneresponsesendowedwithbothpreventiveandtherapeuticproperties
AT katochk developmentofapotentinvigoratorofimmuneresponsesendowedwithbothpreventiveandtherapeuticproperties
AT paridask developmentofapotentinvigoratorofimmuneresponsesendowedwithbothpreventiveandtherapeuticproperties
AT reddipp developmentofapotentinvigoratorofimmuneresponsesendowedwithbothpreventiveandtherapeuticproperties
AT ahmedn developmentofapotentinvigoratorofimmuneresponsesendowedwithbothpreventiveandtherapeuticproperties
AT sainiv developmentofapotentinvigoratorofimmuneresponsesendowedwithbothpreventiveandtherapeuticproperties
AT guptas developmentofapotentinvigoratorofimmuneresponsesendowedwithbothpreventiveandtherapeuticproperties
_version_ 1718403846774980608